Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Refractory TumorsMalignant Tumors
Interventions
DRUG
Topotecan, Temozolomide
Trial Locations (1)
94805
Institut Gustave Roussy, Villejuif
All Listed Sponsors
lead
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
NCT00412503 - Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents | Biotech Hunter | Biotech Hunter